Cargando…
PD-L1 biology in response to chemotherapy in vitro and in vivo in ovarian cancer
Autores principales: | Grabosch, Shannon, Zeng, Feitianzhi, Zhang, Lixin, Strange, Mary, Brozick, Joan, Edwards, Robert P, Vlad, Anda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649395/ http://dx.doi.org/10.1186/2051-1426-3-S2-P302 |
Ejemplares similares
-
Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles
por: Grabosch, Shannon, et al.
Publicado: (2018) -
Effects of Kras activation and Pten deletion alone or in combination on MUC1 biology and epithelial to mesenchymal transition in ovarian cancer
por: Zhang, Lixin, et al.
Publicado: (2016) -
Longitudinal Modulation of Loco-Regional Immunity in Ovarian Cancer Patients Receiving Intraperitoneal Chemotherapy
por: Suarez Mora, Adria, et al.
Publicado: (2022) -
MUC1 Positive, Kras and Pten Driven Mouse Gynecologic Tumors Replicate Human Tumors and Vary in Survival and Nuclear Grade Based on Anatomical Location
por: Tirodkar, Tejas S., et al.
Publicado: (2014) -
Prognostic and biologic significance of high LCK expression in ovarian cancer
por: Jazaeri, Amir, et al.
Publicado: (2015)